| Research
Structural Studies of Receptor Tyrosine Kinases
Many important cellular signaling cascades are initiated at the cell
surface by the binding of a polypeptide ligand to a transmembrane receptor
possessing intrinsic tyrosine kinase activity in its cytoplasmic domain.
The receptor tyrosine kinase (RTK) family includes, among others, the insulin
receptor, insulin-like growth factor-1 (IGF1) receptor, epidermal growth
factor receptor, fibroblast growth factor receptor and MuSK, the receptor
for agrin. Ligand binding induces receptor oligomerization (growth factor
receptors) or a conformational change within the receptor (insulin/IGF1
receptor), leading to autophosphorylation of specific tyrosine residues
in the cytoplasmic domains of the receptors. Tyrosine autophosphorylation
stimulates receptor catalytic activity and generates recruitment sites
for downstream signaling proteins. RTKs are critical components in signal
transduction pathways that mediate cell proliferation, differentiation,
migration and metabolism, and are active during organismal development
and adult homeostasis. RTKs also play primary roles in the onset or progression
of pathological conditions such as diabetic retinopathy, atherosclerosis
and cancer.
Insulin Receptor
Using x-ray crystallography as our primary experimental technique,
we are attempting to understand the molecular basis for insulin receptor
activation and for recruitment of downstream signaling proteins to the
activated (phosphorylated) insulin receptor. Several cytoplasmic adapter
proteins bind to the activated insulin receptor, including insulin receptor
substrate (IRS) proteins and APS, which are positive factors in insulin
signaling pathways culminating in glucose uptake. The insulin receptor
is downregulated by the adapter proteins Grb10 and Grb14 as well as the
tyrosine phosphatase PTP1B. We are determining crystal structures of complexes
between these proteins and the insulin receptor kinase domain to elucidate
the modes of interaction and the determinants of specificity.
 |
| The KRLB region of IRS2 bound to tris-phosphorylated
IRK. The N-terminal kinase lobe is colored dark gray, the C-terminal lobe
is colored light gray, and the KRLB region (residues 620-634) is shown in stick represenetation. Atoms of the activation
loop and catalytic loop of IRK are colored green and orange, respectively.
[Wu et al., Nat. Struct. Mol. Biol. (in press, 2008)] |
 |
| The BPS region of Grb14 bound to tris-phosphorylated
IRK. The N-terminal kinase lobe is colored dark gray, the C-terminal lobe
is colored light gray, and the BPS region is colored purple. The activation
loop and catalytic loop of IRK are colored green and orange, respectively.
[Depetris et al., Mol. Cell 20, 325-333 (2005)] |
 |
| APS SH2 dimer bound to tris-phosphorylated IRK.
The two APS(SH2) protomers are colored orange and blue, and the
two IRK molecules are shown with a semi-transparent surface.
[Hu et al., Mol. Cell 12, 1379-1389 (2003)] |
IGF1 Receptor
The IGF1 receptor is highly related in sequence and structure to the
insulin receptor, but has distinct biological functions, one of which is
cell survival. Therefore, this RTK is a potential target for inhibition
in tumor cells. In collaboration with Dr. Todd Miller at SUNY-Stony Brook,
we have determined the three-dimensional structure of the IGF1 receptor
kinase domain using x-ray crystallography. Several amino acid differences
between the IGF1 receptor and the insulin receptor near the ATP binding
cleft might be exploited by small-molecule inhibitors to gain selectivity
for the IGF1 receptor over the insulin receptor. To this end, structural
studies of inhibitors bound to the IGF1 receptor kinase are being pursued.
 |
| Surface representation of the IGF1 receptor tyrosine
kinase domain. The bound ATP analog and substrate peptide are shown in
stick representation. Colored green and yellow are the residues that differ
between the IGF1 receptor and the insulin receptor. [Favelyukis et al.,
Nat. Struct. Biol. 18, 1058-1063 (2001)] |
MuSK
Another RTK of interest is MuSK, or muscle-specific kinase, which is
expressed exclusively in muscle cells and plays an essential role in the
formation of neuromuscular synapses by promoting clustering of acetylcholine
receptors. Activation of MuSK by agrin results in autophosphorylation of
several tyrosines in the cytoplasmic domain of MuSK. In a collaboration
with Dr. Steven Burden at the NYU School of Medicine, we have determined
the crystal structure of the cytoplasmic (tyrosine kinase-containing) domain
of MuSK to understand how kinase activity is regulated in this receptor.
The structure reveals that MuSK is strongly autoinhibited by the kinase
activation loop and suggests that an additional in vivo component might
contribute to negative regulation by binding to the juxtamembrane region
of MuSK.
 |
| Ribbon diagram of the tyrosine kinase domain of MuSK.
Beta strands are colored cyan and alpha helices are colored red/yellow.
The juxtamembrane region and activation loop are colored green. The activation
loop contains three tyrosine autophosphorylation sites whose side chains
are colored black. Disordered regions of the structure are represented
as dashed lines. [Till et al., Structure 10, 1187-1196 (2002)] |
We have also determined the crystal structure of the first two immunoglobulin-like
domains (Ig1-2) of the MuSK extracellular region. These domains are critical
for activation of the receptor by agrin. Ig1-2 crystallized as a dimer,
mediated by Ig1, and the residues in the dimer interface are critical for
agrin-induced phosphorylation of the receptor. Whether these residues are
important for receptor dimerization or for a heterologous interaction (e.g.,
with agrin or a co-receptor) is still under investigation.
 |
| Molecular surface representation of dimeric Ig1-2 of
the MuSK ectodomain. Ig1 is colored light green/purple, and Ig2 is colored
dark green/purple. The dimer interface is mediated solely by residues
in Ig1. [Stiegler et al., J. Mol. Biol. 364, 424-433 (2006)] |
|